The evidence leans constructive7 supporting, 0 against, 0 worth knowing
Supporting
trading 37% above its 200-day average
sitting at 86% of its 52-week range, with little overhead supply from trapped buyers
up 74% over twelve months
matches long tail above — rejected higher, which has beaten the market by +0.39 points over 20 sessions across 16,308 past signals
5 independent kinds of evidence agree today, which is uncommon
revenue grew 62% year on year in the quarter ending 2026-06-30
net margin has widened from 12.7% to 13.5% across four quarters
Against
nothing the data supports either way
Worth knowing
nothing the data supports either way
What would change this read: a close below 3,351, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
How it has performed
price return over each window, measured against zero
What the scans say today
9 of 47 matched on 2026-08-21
ASMTEC matches 9 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 62% against the same quarter a year earlier
profit rose 72% year on year
net margin widened from 8.0% to 13.5%
revenue rose in 2 of the last 3 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
199
39
27
18.39
13.5%
Q3 FY26
2025-12-31 · consolidated
116
13
9
6.38
8.0%
Q2 FY26
2025-09-30 · consolidated
277
48
35
23.76
12.5%
Q1 FY26
2025-06-30 · consolidated
123
21
16
10.67
12.7%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+5.8%
Versus 200-day average+36.5%
Below 52-week high-7.8%
Above 52-week low+113.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)39.0
Higher closes in last 52 of 5
Six-month return+70.70%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)4.44%
Volume versus 20-day0.3x
Median daily turnoverRs 12.3 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.